Raymond James & Associates’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$114K	Buy	30,613 +2,000	+7%	+$7.44K	﹤0.01%	3729
2024 Q2	$181K	Buy	28,613 +5,200	+22%	+$32.9K	﹤0.01%	3596
2024 Q1	$126K	Buy	+23,413	New	+$126K	﹤0.01%	3666
2021 Q1	–	Sell	-62,125	Closed	-$828K	–	3866
2020 Q4	$828K	Buy	+62,125	New	+$828K	﹤0.01%	2453